2014
DOI: 10.1039/c4ob00679h
|View full text |Cite
|
Sign up to set email alerts
|

An efficient synthesis of methyl 2-cyano-3,12-dioxoursol-1,9-dien-28-oate (CDDU-methyl ester): analogues, biological activities, and comparison with oleanolic acid derivatives

Abstract: An efficient synthesis of methyl 2-cyano-3,12-dioxoursol-1,9-dien-28-oate (CDDU-methyl ester) from commercially available ursolic acid, which features an oxidative ozonolysis-mediated C-ring enone formation, and provides the first access to ursolic acid-derived cyano enone analogues with C-ring activation. These new ursolic acid analogues show potent biological activities, with potency of approximately five-fold less than the corresponding oleanolic acid derivatives.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 32 publications
(50 reference statements)
0
6
0
Order By: Relevance
“…Acrylodan (Anaspec) was solubilized in acetonitrile, with the stock concentration determined by absorbance at 393 nm on dilution into methanol (ε = 18,483 M −1 cm −1 per manufacturer’s data sheet). Compounds were obtained as follows: compounds 1–5 , gift from Gordon Gribble and Michael Sporn (Dartmouth University); 4550 compounds 6–8 and 15 were provided by the Developmental Therapeutics Program (DTP/NIH); compounds 9–14 and 16–17 were synthesized as described in the Supporting Information; estrone ( 15 ) was purchased from Cayman Chemical (Ann Arbor, MI); cyclohexenone ( 18 ) was purchased from Alfa Aesar (Ward Hill, MA). The GSSFLC NH2 peptide for fluorescent labeling with acrylodan was synthesized by Sigma–Genosys (The Woodlands, TX, USA) in the Pepscreen format.…”
Section: Methodsmentioning
confidence: 99%
“…Acrylodan (Anaspec) was solubilized in acetonitrile, with the stock concentration determined by absorbance at 393 nm on dilution into methanol (ε = 18,483 M −1 cm −1 per manufacturer’s data sheet). Compounds were obtained as follows: compounds 1–5 , gift from Gordon Gribble and Michael Sporn (Dartmouth University); 4550 compounds 6–8 and 15 were provided by the Developmental Therapeutics Program (DTP/NIH); compounds 9–14 and 16–17 were synthesized as described in the Supporting Information; estrone ( 15 ) was purchased from Cayman Chemical (Ann Arbor, MI); cyclohexenone ( 18 ) was purchased from Alfa Aesar (Ward Hill, MA). The GSSFLC NH2 peptide for fluorescent labeling with acrylodan was synthesized by Sigma–Genosys (The Woodlands, TX, USA) in the Pepscreen format.…”
Section: Methodsmentioning
confidence: 99%
“…For example, glycyrrhetinic acid has been used for the synthesis of CDDO analogs (soloxolones), which significantly improved cytotoxicity [ 11 , 12 , 13 ], and recently the effective inhibition by methyl soloxolone TGF-β-driven EMT of tumor cells was shown [ 14 ]. The same ursane-type analogs were obtained by an oxidative ozonolysis-mediated C-ring enone formation with a potency of approximately five-fold less than the corresponding oleanolic acid derivatives [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…In recent reports, a large number of oleanolic acid derivatives were designed, synthesized, and evaluated for antitumor activity, in particular as potential anti-hepatic carcinoma and anti-fibrotic agents, which had made outstanding progresses [21,23]. The hepatoprotective activity of OA could be due to its anti-oxidant and anti-inflammatory effects, as well as its effect on drug-metabolizing enzymes [13].…”
Section: Discussionmentioning
confidence: 99%
“…Oleanolic acid (OA), an oleanane-type triterpenoid that belongs to the pentacyclic triterpene family, is well known for protective activity for the treatment of liver injury, chronic liver fibrosis, cirrhosis, and hepatic carcinoma [13]. In recent reports, due to its favorable properties, OA had been used as a base molecule for further synthetic modifications to develop lead compounds, in particular as potential anti-tumor and anti-fibrotic agents [14,15,16,17,18,19,20,21,22,23]. In the previous report, the lead compound TOA exhibited promising anticancer effects in vitro and in vivo [24,25,26].…”
Section: Introductionmentioning
confidence: 99%